drugset

drugset / Trial / NCT00692185

Effectiveness of Olanzapine Versus Placebo in Treating Outpatients With Anorexia Nervosa

NCT00692185 ↗

Phase 2 Completed 23 enrolled New York State Psychiatric Institute National Institute of Mental Health (NIMH) · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the effectiveness of the antipsychotic medication olanzapine in treating outpatients with anorexia nervosa.

Timeline

Start: 2005-10
Primary completion: 2010-09
Completion: 2010-09

Publications

Attia E, Kaplan AS, Walsh BT, Gershkovich M, Yilmaz Z, Musante D, Wang Y. Olanzapine versus placebo for out-patients with anorexia nervosa. Psychol Med. 2011 Oct;41(10):2177-82. doi: 10.1017/S0033291711000390. Epub 2011 Mar 22.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Olanzapine	Small molecule	2.5 mg	—
Subject	Olanzapine	Small molecule	5 mg	—
Subject	Olanzapine	Small molecule	10 mg	—

Indications